Eduardus F. M. Posthuma

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Appetite suppression through smelling of dark chocolate correlates with changes in ghrelin in young women

Elske T. Massolt, P.M.M. van Haard, Jens F. Rehfeld et al. · Regulatory Peptides · 2010 · 62 citations

Life Sciences, Nutritional Sciences, Physiology +11

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

Eduardus F. M. Posthuma, Erik W.A. Marijt, Renée M. Y. Barge et al. · Biology of Blood and Marrow Transplantation · 2004 · 48 citations · Full text

Medicine, Hematology, Immunology +14

The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands

Avinash G. Dinmohamed, Yvette van Norden, Otto Visser et al. · Leukemia Research · 2014 · 43 citations

Medicine, Hematology, Clinical Epidemiology +15

Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

Lina van der Straten, Mark‐David Levin, Manette A. W. Dinnessen et al. · Blood Cancer Journal · 2023 · 37 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16